MIS416 Multiple Sclerosis Trial Results MStranslate June 28, 2017 MIS416, Research, Treatments On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...
Warwick: From Medieval Times to MStranslate MStranslate June 21, 2017 Community, MStranslate Warwick, England. Famously known as the home of Warwick Castle, an amazing castle built by William the Conqueror in 1068. The town is situated on the River Avon and is one of those places that just exudes...
Multiple Sclerosis Treatment Overview: AHSCT MStranslate June 13, 2017 Stem Cells, Treatments 1 Comment Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS research. These events generally involve me giving a small...
Genetics & MS: Can It Be Inherited? MStranslate June 6, 2017 Uncategorized Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS research. These events generally involve me giving a small...
Health Impacts of Interferon-beta Use in MS MStranslate May 16, 2017 Interferon-beta, Research, Treatments Research Summary: Evaluating the safety of β-interferons in MS Research from the University of British Columbia has looked at the long-term health effects of interferon-beta treatment in people with...
Secondary Progressive Multiple Sclerosis & Statins MStranslate May 15, 2017 Research, Treatments There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS). The study is being led by University College London and will involve over 1100 people...
Multiple Sclerosis Clinical Trial Update: Laquinimod MStranslate May 9, 2017 Clinical Trials, Laquinimod, Research What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS). The...
Multiple Sclerosis Treatment Information: Daclizumab MStranslate May 3, 2017 Daclizumab, Treatments It has been reported this week that daclizumab (marketed as Zinbryta) has been added to the Pharmaceutical Benefits Scheme (PBS) in Australia. Considering this, we thought it appropriate to provide some more...
BMI & Lipid Levels Impact MS Progression MStranslate April 26, 2017 Diet, Lifestyle, Research 2 Comments Research Summary: An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event An increasing emphasis is being placed on how lifestyle...
Multiple Sclerosis: One Disease, Many Causes? MStranslate April 18, 2017 Research, Understanding Science 1 Comment In one of our recent Facebook Live Q&A sessions, I was asked what I thought the biggest hurdle was that needed to be overcome in multiple sclerosis research. Whilst funding problems are something that we...
